Discussion Among US adults with T2D and ASCVD, combination therapy with SGLT2i and GLP-1RA was associated with reduced incidence rates and risks of CV outcomes, including ischemic stroke, MI, 3-point MACE, and 5-point MACE, compared with SGLT2i alone
This has led some people to consider it a quick fix for losing weight by using it exclusively for cosmetic reasons
4,6,7 Opioid replacement therapy not only mitigates these changes in neurotransmitters but is also associated with apoptosis, white and grey matter injury, altered redox homeostasis, and changes in oligodendroglial maturation and myelination, which may be particularly damaging in the developing brain
Key difficulties include optimizing liposomal formulation for stability and reproducibility, ensuring efficient stimulus-triggered drug release, and maintaining safety and biocompatibility [95]
If you compete in a sport that is a WADA signatory, that is the starting and ending point